Impact of novel TRIM5α variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection

Objective:TRIM5α is one of the factors contributing to intracellular defense mechanisms against HIV-1 infection. We investigated the association of TRIM5α sequence variations with the susceptibility to HIV-1 infection in Japanese and Indian. Design:Sequence variations in TRIM5α were investigated in HIV-1-infected patients and ethnic-matched controls. Functional alterations caused by rare variants were analyzed. Methods:We sequenced TRIM5α-exon 2 in both Japanese (94 HIV-1-infected patients and 487 controls) and Indian (101 HIV-1-infected patients and 99 controls). Frequency of variants and haplotypes were compared between the HIV-1-infected patients and controls. Functional analyses were performed for two rare variants, Gly110Arg and G176del. Results:The frequency of 43Tyr-allele in the Indian HIV-1-infected patients was significantly lower than that in the ethnic-matched controls (odds ratio = 0.52, 95% confidence interval = 0.31–0.89, P = 0.015). A similar tendency was observed in Japanese sample, although it was not statistically significant (odds ratio = 0.67, 95% confidence interval = 0.43–1.05, P = 0.095). On the other hand, haplotype analyses revealed that the haplotype carrying the 43Tyr-allele was significantly associated with the reduced susceptibility to HIV-1 infection in both ethnic groups. Functional analysis revealed that Gly110Arg variant weakened the anti-HIV-1 and anti-HIV-2 activities of human TRIM5α, whereas the truncated G176del-TRIM5 enhanced the antiviral activity of coexpressed TRIM5α. Epidemiological data were consistent in that Gly110Arg and G176del were associated with the susceptibility to and protection from HIV-1 infection, respectively. Conclusion:Both common and rare variants of TRIM5α are associated with the susceptibility to HIV-1 infection.

[1]  F. S. Domingues,et al.  Impact of a single amino acid in the variable region 2 of the Old World monkey TRIM5alpha SPRY (B30.2) domain on anti-human immunodeficiency virus type 2 activity. , 2009, Virology.

[2]  R. Paranjape,et al.  HIV infection in India: Epidemiology, molecular epidemiology and pathogenesis , 2008, Journal of Biosciences.

[3]  K. Ozato,et al.  TRIM family proteins and their emerging roles in innate immunity , 2008, Nature Reviews Immunology.

[4]  J. Sodroski,et al.  The TRIM5α B-Box 2 Domain Promotes Cooperative Binding to the Retroviral Capsid by Mediating Higher-Order Self-Association , 2008, Journal of Virology.

[5]  T. Shioda,et al.  Silencing of tripartite motif protein (TRIM) 5alpha mediated anti-HIV-1 activity by truncated mutant of TRIM5alpha. , 2008, Journal of virological methods.

[6]  T. Shioda,et al.  Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection. , 2008, Virology.

[7]  H. Schuitemaker,et al.  The Effect of Trim5 Polymorphisms on the Clinical Course of HIV-1 Infection , 2008, PLoS pathogens.

[8]  T. Nakajima,et al.  Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia , 2007, Immunogenetics.

[9]  J. Sodroski,et al.  Modulation of Retroviral Restriction and Proteasome Inhibitor-Resistant Turnover by Changes in the TRIM5α B-Box 2 Domain , 2007, Journal of Virology.

[10]  M. Massiah,et al.  Solution structure of the MID1 B-box2 CHC(D/C)C(2)H(2) zinc-binding domain: insights into an evolutionarily conserved RING fold. , 2007, Journal of molecular biology.

[11]  J. Levy,et al.  A Single Amino Acid of the Human Immunodeficiency Virus Type 2 Capsid Affects Its Replication in the Presence of Cynomolgus Monkey and Human TRIM5αs , 2007, Journal of Virology.

[12]  S. Matsushita,et al.  Wild type and H43Y variant of human TRIM5α show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro , 2007, Immunogenetics.

[13]  J. Levy,et al.  A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. , 2007, Journal of virology.

[14]  J. Sodroski,et al.  The Human TRIM5α Restriction Factor Mediates Accelerated Uncoating of the N-Tropic Murine Leukemia Virus Capsid , 2006, Journal of Virology.

[15]  M. Dittmar,et al.  Human TRIM5α mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants , 2006, Retrovirology.

[16]  Roger Detels,et al.  Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection , 2006 .

[17]  T. Hope,et al.  Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Joseph Sodroski,et al.  Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  John Bui,et al.  Genetic Association of the Antiviral Restriction Factor TRIM5α with Human Immunodeficiency Virus Type 1 Infection , 2006, Journal of Virology.

[20]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[21]  Sara L. Sawyer,et al.  High-Frequency Persistence of an Impaired Allele of the Retroviral Defense Gene TRIM5α in Humans , 2006, Current Biology.

[22]  S. O’Brien,et al.  Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. , 2006, Virology.

[23]  S. Oka,et al.  HLA-B polymorphism in Japanese HIV-1-infected long-term surviving hemophiliacs. , 2005, Viral immunology.

[24]  J. Sodroski,et al.  The Contribution of RING and B-box 2 Domains to Retroviral Restriction Mediated by Monkey TRIM5α* , 2005, Journal of Biological Chemistry.

[25]  Y. Nagai,et al.  A Specific Region of 37 Amino Acid Residues in the SPRY (B30.2) Domain of African Green Monkey TRIM5α Determines Species-Specific Restriction of Simian Immunodeficiency Virus SIVmac Infection , 2005, Journal of Virology.

[26]  A. Yang,et al.  Human Tripartite Motif 5α Domains Responsible for Retrovirus Restriction Activity and Specificity , 2005, Journal of Virology.

[27]  J. Sodroski,et al.  Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5α Determines the Potency of Human Immunodeficiency Virus Restriction , 2005, Journal of Virology.

[28]  Michael Emerman,et al.  Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Kaslow,et al.  Influence of host genetic variation on susceptibility to HIV type 1 infection. , 2005, The Journal of infectious diseases.

[30]  Jonathan P. Stoye,et al.  A Single Amino Acid Change in the SPRY Domain of Human Trim5α Leads to HIV-1 Restriction , 2005, Current Biology.

[31]  S. Nisole,et al.  Trim5α protein restricts both HIV-1 and murine leukemia virus , 2004 .

[32]  Stephen J O'Brien,et al.  Human genes that limit AIDS , 2004, Nature Genetics.

[33]  C. M. Owens,et al.  The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.

[34]  M. Malim,et al.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.

[35]  Y. Takebe,et al.  The molecular epidemiology of HIV in Asia. , 1994, AIDS.